This document describes electrosomes, which are a novel surface display system that allows multiple electron release from fuel oxidation using a scaffoldin protein and cascade of redox enzymes. Electrosomes consist of a hybrid anode with ethanol-oxidizing enzymes attached to scaffoldin and a hybrid cathode with an oxygen-reducing enzyme also attached to scaffoldin. This allows the electrosomes to function as both an anode and cathode in a biofuel cell. Characterization of the electrosomes showed they were able to catalyze the conversion of chemical energy from ethanol to electricity with high power outputs due to the enzymatic cascades in the anode. Potential applications of electrosomes include use in enzymatic fuel cells, drug targeting
Electrosomes
Mr. Dighe AjinkyaD
M- Pharm 1st year, Sem II (Pharmaceutics)
Guided By - Ms. Bidkar Mam
Presented At- Sharadchandra Pawar Collage Of Pharmacy Otur
INTRODUCTION
• These arethe transmembrane protein generate and propagate the electrical signals that
allow us to sense our surroundings, process, information, make decisions, and move.
• Ion channel proteins act as gates that span the lipid bilayer that surrounds all
electrochemical gradients.
• The ion flux through a channel pore can be extremely high.
• They are high resolution in function and 3D structure to description of their molecules.
• The high resolution structure of ion channel and ion channel associated protein are
providing the substrates for sophisticated tests of the mechanisms of channel gating and
permeation.
• Ion perform two basic function open and close to control the passage of ion across the cell
membrane.
• The electrosomes,a novel surface-display system based on the specific interaction
between the cellulosomal scaffoldin protein and a cascade of redox enzymes that
allows multiple electron-release by fuel oxidation.
• The electrosomes is composed of two compartment:
(i) a hybrid anode, which consists of dockerin-containing enzymes
attached specifically to cohesin sites in the scaffoldin to assemble an ethanol
oxidation cascade, and
(ii) a hybrid cathode, which consists of a dockerin-containing oxygen-
reducing enzyme attached in multiple copies to the cohesin-bearing scaffoldin.
6.
• The electrosomeswas designed for use both in an anode and a cathode compartment; in
each compartment, the unique attributes of the cellulosome scaffoldin give a different
advantage
• In the anode, the ethanol oxidation cascade consists of two enzymes, ADH and
formaldehyde dehydrogenase (FormDH), both containing a different dockerin module of
Acetivibrio cellulolyticus and of Clostridium thermocellum, C. thermocellum (zADH-Ac and
pFormDH-Ct), respectively, assembled on a ‘designer’-scaffoldin chimera displayed on
the surface of S. cerevisiae.
• At the cathode, copper oxidase (CueO) was selected for surface-display. CueO is a multi-
copper oxidase enzyme expressed by E. coli that catalyzes the oxidation of Cu(I) ions
coupled to oxygen reduction to water.
• The different constructs used for assembly are depicted. We report the characterization of
the dockerin-containing enzymes and their electrochemical activity using a diffusing redox
mediator.
9.
Method of Preparation
1.Strains and Constructs method.
2. Enzyme Binding to Scaffoldin.
3. Biofuel-Cell Assembly and Characterization.
4. Protein Expression.
5. Enzyme Activity Assays.
6. Construction of YSD of Chimeric Scaffoldins.
7. Cyclic Voltammetry (CV) and Chronoamperometry (CA).
10.
Strains and Constructsmethod
• The genes encoding dockerins of Acetivibrio cellulolyticus and Clostridium thermocellum
were cloned and ligated to the C-terminus of Zymomonas mobilis alcohol dehydrogenase
and to Pseudomonasputida formaldehyde dehydrogenase by standard methods.
• The dockerin module of C.thermocellum was also ligated to the C-terminus of CueO (CueO-
Ct) of E.coli.
• All the dockerin-containing enzymes encoding genes have been cloned into the pET15b
vector for expression in E. coli, yielding the pET15b-zADH-Ac, pET15b- pFormDH-Ct, and
pET15b-CueO-Ct vectors.
• For controls, the genes encoding the native enzymes without an appended dockerin module
were also cloned in the same vector, yielding plasmids pET15b- zADH, pET15b-pFormDH,
and pET15b-CueO.
11.
Enzyme Binding toScaffoldin
• 2.0 mL of yeast cells displaying scaffoldin, for which absorbance at a wavelength of 600 nm
was 1.0 , were incubated with bacterial lysates containing the expressed enzymes at room
temperature for 1 h. 1.0 mL of the bacterial lysates were used for the binding, which was
performed in a final volume of 15 ml.
• As a binding buffer, 50 mM Tris buffer at pH 8.0 with 1 mM CaCl2 was used. Upon binding,
the yeast cells were precipitated, and binding was repeated using fresh lysate.
• After the second binding cycle, the yeast cells were washed four times in the buffer to
remove non-specifically bound enzymes.
• For the CueO-Ct binding, the yeast cells were suspended in 0.1m acetate buffer pH 5.0
containing 1 mm CaCl2 after the last wash.
• Following binding, the yeast cells were resuspended in 2.0 ml of buffer
12.
Biofuel-Cell Assembly andCharacterization
• Air was continuously purged to the fuel-cells. A potentiostatically controlled anode set to
−0.2 V versus Ag/AgCl was used.
• In all experiments, the cells were left to stabilize overnight, following fuel cell assembly,
before characterization was performed.
• The characterization of fuel cell performance was done by measuring the voltage of the cells
under variable external loads.
• A background current cell was used as a negative control for all fuel cell experiments and
did not contain any yeast. Graphite rods of 5 mm diameter served as both anodes and
cathodes.
• The counter electrode that served for the potentiostatically controlled electrode was of a
larger surface area, as described for the CV and CA measurements
13.
Advantages
• It perpetuatesthe endurance of active drug molecule in the systemic circulation. Deferment
the elimination reactions of promptly metabolize drugs and contributes to controlled release.
• Incorporates both hydrophilic and lipophilic drugs.
• Intensifies the stability of medicament.
• Cost of therapy is minimized by reducing the dose per unit formulation
• Elevate bioavailability especially in water disfavouring drugs.
• Selective uptake by tissues due to direct drug delivery.
14.
Disadvantages
• The productioncost of electrosomes are generally high since these come under the
class of nanotherapeutics.
• The constituent phospholipids present in lipid vesicular structures may undergo
oxidation or hydrolysis.
15.
Application
• They useenzymatic reactions to catalyze the conversion of chemical energy to electricity in
a fuel cell.
• The use of enzymatic cascades in enzymatic fuel cell anodes resulted in very high power
outputs, as the electron density achieved was much higher when the fuel was fully oxidized.
• Its used as a carrier in drug targeting.
• Used in the treatment of cancer.
• Used in studying immune response.
• Ear targeting
• Muscle targeting
16.
Reference
1. SHEFRIN S,SREELAXMI C. S, VISHNU VIJAYAN, SREEJA C. NAIR.ENZYMOSOMES:
A RISING EFFECTUAL TOOL FOR TARGETED DRUG DELIVERY SYSTEM.INT J APP
PHARM. 2017;9(6);1-9
2. 2. SZCZUPAK A, AIZIK D, MORAÏS S, VAZANA Y, BARAK Y, BAYER A E, ALFONTA L.
THE ELECTROSOME: A SURFACE-DISPLAYED ENZYMATIC CASCADE IN A BIOFUEL
CELL’S ANODE AND A HIGH-DENSITY SURFACE-DISPLAYED BIOCATHODIC
ENZYME.NANO- MATERIAL.2017
3. 3. WWW.SCIENCE DIRECT.COM